Skip to content
Biotechnology, Business Company News

LTR Pharma Limited (ASX:LTP) Signs National Pharmacy Distribution Agreement with Symbion, Establishing Nationwide Distribution Network for SPONTAN®

Jane Morgan Management 2 mins read

22 January 2025 – Sydney, Australia | ASX-listed LTR Pharma Limited (ASX:LTP) has announced a strategic partnership with Symbion Pty Ltd, which is one of the largest pharmaceutical wholesalers in Australia. This will facilitate the nationwide distribution of novel nasal spray treatment for Erectile Dysfunction (ED), SPONTAN®.

The non-exclusive agreement, which commences on 1 March 2025, enables LTR Pharma to leverage Symbion's extensive network of over 3,900 pharmacies across the country. This collaboration will play a vital role in supporting the early access scheme that LTR will use and sets a new foundation for SPONTAN’s commercial launch following the appropriate regulatory approval process completion.

Highlights

  • LTR Pharma has signed a non-exclusive agreement to partner with Symbion Pty Ltd, a leading pharmaceutical wholesaler.

  • Symbion’s network includes warehousing, inventory functions, and distribution services that are suited to meet the unique requirements of pharmaceutical products.

  • Operational integration is planned for Q2 2025, which includes:

    • Inventory management systems and integration.

    • Quality control and TGA-compliant product handling protocols for pharmaceutical products.

    • Storage facility setups and maintenance.

    • Development of pharmacist education 

    • Development of product support materials.

  • The partnership aligns with LTR Pharma’s commitment to delivering rapid and reliable patient access to SPONTAN.

Comments from LTR Pharma Chairman, Lee Rodne: "Partnering with Symbion is a pivotal step in building our commercial infrastructure. Symbion’s extensive distribution network and expertise will ensure seamless access to SPONTAN across Australia. This agreement underscores our commitment to collaboration with industry leaders to establish a reliable supply chain, support the TGA’s early access program, and prepare for SPONTAN’s anticipated commercial launch. Together, we are ensuring the highest standards of pharmaceutical handling and service delivery”

For more information, visit www.ltrpharma.com.

Jane Morgan
Jane Morgan Management
Investor & Media Relations
jm@janemorganmanagement.com.au

Peter McLennan
Chief Operating Officer
investors@ltrpharma.com


About us:

About LTR Pharma Limited:

LTR Pharma is focused on improving men’s health, physically and mentally, through the commercialisation of an innovative nasal spray treatment for Erectile Dysfunction. ED is a pressing health issue for millions of men that can negatively impact self-esteem and relationships, across multiple age brackets. LTR Pharma’s lead product SPONTAN® is set apart from existing ED therapies by its mechanism of action – intranasal delivery technology of a PDE5 inhibitor. The nasal cavity is a highly vascular part of the body supporting even and rapid absorption of the drug, empowering it to work within 10 minutes or less. LTR Pharma is proudly aiming to restore greater control over the timing, spontaneity, and enjoyment of sexual experiences.


Contact details:

Jane Morgan 
Jane Morgan Management
Investor & Media Relations
jm@janemorganmanagement.com.au

Media

More from this category

  • Business Company News, Finance Investment
  • 14/02/2025
  • 16:20
Visby Management

Visby Management Doubles Initial Cash Payment Above Tiger Gold Offer For LCL Resources Colombia Assets

Visby Management February 13, 2025 On February 11, 2025 Visby Management (“Visby”), an international mine operator with operations in Colombia, made two binding offers to Los Cerros Limited (“LCL”) for the purchase of the company’s Andes and Quinchia Colombia assets. Offer A is a $6,000,000 AUD all-cash offer with the full amount to be paid within one year. Offer B is a cash and stock offer identical to the offer made by Tiger Gold Corporation with an additional $1,000,000 AUD up-front payment. The total up-front payment offered by Visby in Offer B is $2,000,000 AUD. Visby requested that both offers…

  • Business Company News, Women
  • 14/02/2025
  • 12:17
Belmont Business Forum

EMPOWER WOMEN, BUILD SKILLS, CREATE CHANGE WITH THE BEC VOLUNTEER EMPOWERMENT PROJECT

We are excited to announce the launch of the BEC Volunteer Empowerment Project - a new initiative designed to empower women by providing free online training, mentoring, and networking opportunities. The project aims to focus on increasing skills, self-development, and economic awareness for women from diverse backgrounds. So, if you're passionate about supporting women’s empowerment, we invite you to get involved! You will be able to engage in a variety of impactful topics, including: The BEC Volunteer Empowerment Project specifically targets volunteers and women from culturally and linguistically diverse, disabled, Indigenous, and other vulnerable groups with the goal to upskill…

  • Business Company News, Women
  • 14/02/2025
  • 12:10
Belmont Business Enterprise Centre

Economic Empowerment of Women Entrepreneurs, Gender Equality, Sustainable Development Goals

Carol Hanlon, Founder/CEO, Belmont Business Enterprise Centre Inc. (Belmont BEC | BEC Global), TCF WA Inc. (TCF Global) and BPW Business Incubator, will be presenting in New York at the NGO CSW69 Forum, ‘Economic Empowerment of Women Entrepreneurs, Gender Equality, and Sustainable Development Goals’. The forum will be hosted by NGO CSW, which is a coalition of many global non-government organisations, civil societies and individuals that are concerned and working towards the world-wide attainment of women’s human rights, gender equality and empowerment of women and girls on an international level. Their mission is to provide an international platform for the…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.